A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
NCT06147895
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Vaccine-Preventable Diseases
Hepatitis B
Interventions
BIOLOGICAL:
CVI-HBV-002
Sponsor
CHA Vaccine Institute Co., Ltd.